Clinical trials recruiting for Metastasis

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
  NCT06863272 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 82 locations
• A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases
  NCT06567353 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• A Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC
  NCT07562581 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
  NCT06362369 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.
  NCT06700057 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 1 location
• Definitive Radiation for High-Risk Spine Metastases
  NCT06165419 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung
  NCT06712745 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer
  NCT04743102 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
  NCT05542407 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Female · 1 location
• Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients
  NCT06690970 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 3 locations
• Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast Cancer
  NCT07154563 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
  NCT06993506 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 19 locations
• The Impact of Radiotherapy on Oligometastatic Cancer
  NCT05933876 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 21 locations
• Validation of a miRNA Panel to Optimize Treatment Response in Patients With Metastatic Pancreatic Cancer (mirPANC 2)
  NCT06945978 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Metastasis often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Metastasis trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.